NDC 30698-121

ANZEMET

Dolasetron Mesylate

ANZEMET is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Validus Pharmaceuticals Llc. The primary component is Dolasetron Mesylate.

Product ID30698-121_fc7a7002-d1d6-40f2-9a44-44ce51686152
NDC30698-121
Product TypeHuman Prescription Drug
Proprietary NameANZEMET
Generic NameDolasetron Mesylate
Dosage FormTablet, Film Coated
Route of AdministrationORAL
Marketing Start Date1997-09-11
Marketing CategoryNDA / NDA
Application NumberNDA020623
Labeler NameValidus Pharmaceuticals LLC
Substance NameDOLASETRON MESYLATE
Active Ingredient Strength100 mg/1
Pharm ClassesSerotonin 3 Receptor Antagonists [MoA],Serotonin-3 Receptor Antagonist [EPC]
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 30698-121-05

5 TABLET, FILM COATED in 1 BOTTLE (30698-121-05)
Marketing Start Date1997-09-11
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 30698-121-05 [30698012105]

ANZEMET TABLET, FILM COATED
Marketing CategoryNDA
Application NumberNDA020623
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date1997-09-11

Drug Details

Active Ingredients

IngredientStrength
DOLASETRON MESYLATE100 mg/1

OpenFDA Data

SPL SET ID:201b0eb8-4a1e-4e22-ab4b-addb642710d6
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 310006
  • 213092
  • 213091
  • 310007
  • Pharmacological Class

    • Serotonin 3 Receptor Antagonists [MoA]
    • Serotonin-3 Receptor Antagonist [EPC]
    • Serotonin 3 Receptor Antagonists [MoA]
    • Serotonin-3 Receptor Antagonist [EPC]

    NDC Crossover Matching brand name "ANZEMET" or generic name "Dolasetron Mesylate"

    NDCBrand NameGeneric Name
    30698-120ANZEMETdolasetron mesylate
    30698-121ANZEMETdolasetron mesylate
    30698-220ANZEMETdolasetron mesylate

    Trademark Results [ANZEMET]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    ANZEMET
    ANZEMET
    74343289 1863035 Live/Registered
    U.S. PHARMACEUTICALS HOLDINGS II, LLC
    1992-12-28

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.